Back
Jasper Therapeutics, Inc. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
37
JSPR
Jasper Therapeutics, Inc.
Last Price:
$1.65
Seasonality Move:
45.02%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JSPR is experiencing slight selling pressure.
Jasper Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.55 | Sell |
| 20-day SMA: | 1.67 | Sell |
| 50-day SMA: | 1.72 | Sell |
| 200-day SMA: | 3.17 | Sell |
| 8-day EMA: | 0.61 | Buy |
| 20-day EMA: | 0.28 | Buy |
| 50-day EMA: | 0.12 | Buy |
| 200-day EMA: | 0.03 | Buy |
Jasper Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 41.51 | Sell |
| Chaikin Money Flow: | -110651 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.54 - 1.86) | Sell |
| Bollinger Bands (100): | (1.68 - 2.46) | Sell |
Jasper Therapeutics, Inc. Technical Analysis
| Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Jasper Therapeutics, Inc. Stock
Is Jasper Therapeutics, Inc. Stock a Buy?
-
Jasper Therapeutics, Inc. share price is 1.53 while JSPR 8-day simple moving average is 1.55, which is a Sell signal.
-
The stock price of JSPR is 1.53 while Jasper Therapeutics, Inc. 20-day SMA is 1.67, which makes it a Sell.
-
Jasper Therapeutics, Inc. 50-day simple moving average is 1.72 while JSPR share price is 1.53, making it a Sell technically.
-
JSPR stock price is 1.53 and Jasper Therapeutics, Inc. 200-day simple moving average is 3.17, creating a Sell signal.
JSPR Technical Analysis vs Fundamental Analysis
Sell
37
Jasper Therapeutics, Inc. (JSPR)
is a Sell
Is Jasper Therapeutics, Inc. a Buy or a Sell?
-
Jasper Therapeutics, Inc. stock is rated a SellThe current Jasper Therapeutics, Inc. [JSPR] share price is $1.53. The Score for JSPR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Jasper Therapeutics, Inc. Stock Info
Market Cap:
45.9M
Price in USD:
1.53
Share Volume:
258.2K
Jasper Therapeutics, Inc. 52-Week Range
52-Week High:
7.19
52-Week Low:
1.39
Sell
37
Jasper Therapeutics, Inc. (JSPR)
is a Sell
Jasper Therapeutics, Inc. Share Price Forecast
-
What is the Jasper Therapeutics, Inc. stock price today?The Jasper Therapeutics, Inc. stock price is 1.53 USD today.
-
Will JSPR stock go up or go down?Jasper Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Jasper Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Jasper Therapeutics, Inc. is overvalued.
Is Jasper Therapeutics, Inc. Stock a Buy?
-
Jasper Therapeutics, Inc. share price is 1.53 while JSPR 8-day exponential moving average is 0.61, which is a Buy signal.
-
The stock price of JSPR is 1.53 while Jasper Therapeutics, Inc. 20-day EMA is 0.28, which makes it a Buy.
-
Jasper Therapeutics, Inc. 50-day exponential moving average is 0.12 while JSPR share price is 1.53, making it a Buy technically.
-
JSPR stock price is 1.53 and Jasper Therapeutics, Inc. 200-day simple moving average is 0.03, creating a Buy signal.
Fundamental Analysis of Jasper Therapeutics, Inc.
Is Jasper Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.81 per share, and an increase next year of $1.26 per share.
Technical Analysis of Jasper Therapeutics, Inc.
Should I short Jasper Therapeutics, Inc. stock?
-
JSPR Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Jasper Therapeutics, Inc. is a Buy
-
Jasper Therapeutics, Inc. Relative Strength Index (RSI) is 41.51, which suggest Jasper Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Jasper Therapeutics, Inc. is (1.54 - 1.86), which suggest Jasper Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Jasper Therapeutics, Inc. is (1.68 - 2.46), which suggest Jasper Therapeutics, Inc. is a Sell
* Jasper Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.